Gsa Capital Partners LLP Avadel Pharmaceuticals PLC Transaction History

Gsa Capital Partners LLP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$12.55 - $17.22 $597,329 - $819,603	47,596 New	47,596 $803,000
Q1 2022 May 11, 2022	SELL	$5.46 - $8.29 $214,430 - $325,573	-39,273 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$7.34 - $11.18 $131,202 - $199,842	-17,875 Reduced 31.28%	39,273 $317,000
Q3 2021 Nov 12, 2021	BUY	$6.49 - $9.91 $27,355 - $41,770	4,215 Added 7.96%	57,148 $560,000
Q2 2021 Aug 05, 2021	BUY	$6.73 - $9.05 $356,239 - $479,043	52,933 New	52,933 $356,000
Q4 2020 Feb 03, 2021	SELL	$5.03 - $7.95 $112,621 - $178,000	-22,390 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$5.02 - $8.98 $39,055 - $69,864	7,780 Added 53.25%	22,390 $113,000
Q2 2020 Aug 11, 2020	BUY	$7.25 - $11.75 $105,922 - $171,667	14,610 New	14,610 $118,000
Q4 2018 Feb 12, 2019	SELL	$1.74 - $4.66 $81,078 - $217,142	-46,597 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$4.08 - $7.14 $769,569 - $1.35 Million	-188,620 Reduced 80.19%	46,597 $205,000
Q2 2018 Aug 09, 2018	SELL	$5.89 - $7.78 $475,576 - $628,180	-80,743 Reduced 25.55%	235,217 $1.44 Million
Q1 2018 May 11, 2018	BUY	$6.76 - $11.7 $438,906 - $759,645	64,927 Added 25.86%	315,960 $2.3 Million
Q4 2017 Feb 14, 2018	BUY	$8.03 - $11.25 $848,048 - $1.19 Million	105,610 Added 72.62%	251,033 $2.06 Million
Q3 2017 Nov 20, 2017	BUY	$8.35 - $10.5 $1.21 Million - $1.53 Million	145,423	145,423 $1.53 Million

1.07M

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $661M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.